Kynos Therapeutics: Funding, Investors & Team (Oct 2026)
Kynos Therapeutics develops KMO inhibitors across key indications in inflammation, immunity, and metabolism.
Kynos Therapeutics has raised $8.5M across 1 funding round on record, the most recent a Seed of $8.5M announced in Apr 2022.
That round is in line with the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Kynos Therapeutics Company Profile and Key Stats
Latest funding round on record: Apr 2022.
Kynos Therapeutics Funding Rounds
Kynos Therapeutics Founders and Leadership Team
Contact details for the Kynos Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →Kynos Therapeutics Funding Compared to Other Biotechnology Startups
Kynos Therapeutics' latest round of $8.5M is in line with the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Kynos Therapeutics in Biotechnology and Edinburgh
Companies Similar to Kynos Therapeutics
R1 Therapeutics is a clinical‑stage biopharmaceutical company focused on discovering and developing new drug…
The perfect package for any general surgical trainee or resident. Progress from beginner to advanced surgical…
Argonaute RNA company research projects build on existing intellectual property.
An innovative C elegans company that serves the biotech, nutrition, and other industries and fields of study…
ViaNautis, previously known as SomaServe, was established in 2018 as a separate entity from UCL under the…
Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…
Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…
Concert Bio helps businesses create optimal microbial communities.
RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…
N4 Pharma is a drug reformulation company focused on developing and out licensing new versions of existing…
Laverock Therapeutics is working on developing a system for suppressing genes, which can be used to create…
Oak hill bio is a clinical-stage rare disease therapeutics company developing life-changing medicines.
Kynos Therapeutics Funding FAQs
What does Kynos Therapeutics do?
Kynos Therapeutics develops KMO inhibitors across key indications in inflammation, immunity, and metabolism.
How much funding has Kynos Therapeutics raised?
Kynos Therapeutics has raised $8.5M across 1 round on record. The most recent is a Seed of $8.5M announced in Apr 2022.
When did Kynos Therapeutics last raise funding?
Kynos Therapeutics' most recent funding round on record is a Seed of $8.5M, announced in Apr 2022.
Who is the CEO of Kynos Therapeutics?
Damian Mole is listed as CEO at Kynos Therapeutics.
Where is Kynos Therapeutics headquartered?
Kynos Therapeutics is based in Edinburgh, United Kingdom.
How many employees does Kynos Therapeutics have?
Kynos Therapeutics is in the 1-10 employee band.
How does Kynos Therapeutics' funding compare to other Biotechnology startups?
Kynos Therapeutics' latest round of $8.5M is in line with the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Kynos Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Kynos Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.